# Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP)

> **NCT01713738** · PHASE1,PHASE2 · COMPLETED · sponsor: **Neufeld, Ellis J, MD, PhD** · enrollment: 36 (actual)

## Conditions studied

- Idiopathic Thrombocytopenic Purpura (ITP)
- Immune Thrombocytopenic Purpura (ITP)

## Interventions

- **DRUG:** rituximab

## Key facts

- **NCT ID:** NCT01713738
- **Lead sponsor:** Neufeld, Ellis J, MD, PhD
- **Sponsor class:** INDIV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05
- **Primary completion:** 2005-12
- **Final completion:** 2005-12
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2012-11-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01713738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01713738, "Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01713738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*